Lack of relationship between TIMP-1 tumour cell immunoreactivity, treatment efficacy and prognosis in patients with advanced epithelial ovarian cancer (Q33902738)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Lack of relationship between TIMP-1 tumour cell immunoreactivity, treatment efficacy and prognosis in patients with advanced epithelial ovarian cancer	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Lack of relationship between TIMP-1 tumour cell immunoreactivity, treatment efficacy and prognosis in patients with advanced epithelial ovarian cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

based on heuristic

inferred from title

author name string

Karina Dahl Steffensen

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Marianne Waldstrøm

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Rikke Kølby Christensen

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Annette Bartels

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Nils Brünner

5

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Anders Jakobsen

6

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

language of work or name

0 references

publication date

7 May 2010

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

185

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Tumor tissue levels of Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) and outcome following adjuvant chemotherapy in premenopausal lymph node-positive breast cancer patients: A retrospective study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882920

5 July 2018

Biology and potential clinical implications of tissue inhibitor of metalloproteinases-1 in colorectal cancer treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882920

5 July 2018

Characterization of anti-TIMP-1 monoclonal antibodies for immunohistochemical localization in formalin-fixed, paraffin-embedded tissue

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882920

5 July 2018

Use of CA-125 to Assess Response to New Agents in Ovarian Cancer Trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882920

5 July 2018

In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882920

5 July 2018

Clinical significance of tissue inhibitor of metalloproteinase expression in gastric carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882920

5 July 2018

Metalloproteinase inhibition and erythroid potentiation are independent activities of tissue inhibitor of metalloproteinases-1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882920

5 July 2018

Tissue inhibitor of metalloproteinase-1 protects human breast epithelial cells against intrinsic apoptotic cell death via the focal adhesion kinase/phosphatidylinositol 3-kinase and MAPK signaling pathway

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-185

21 January 2018

Lack of TIMP-1 tumour cell immunoreactivity predicts effect of adjuvant anthracycline-based chemotherapy in patients (n=647) with primary breast cancer. A Danish Breast Cancer Cooperative Group Study.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-185

21 January 2018

TIMP-1 is significantly associated with objective response and survival in metastatic colorectal cancer patients receiving combination of irinotecan, 5-fluorouracil, and folinic acid

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-185

21 January 2018

Increased expression of tissue inhibitor of metalloproteinase-2 in clear cell carcinoma of the ovary.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-185

21 January 2018

Differential expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 protein and mRNA in epithelial ovarian tumors.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-185

21 January 2018

Dose-effect study of carboplatin in ovarian cancer: a Danish Ovarian Cancer Group study.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-185

21 January 2018

CA-125 criteria for response evaluation in ovarian cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-185

21 January 2018

Toward the development of a universal grading system for ovarian epithelial carcinoma: testing of a proposed system in a series of 461 patients with uniform treatment and follow-up.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-185

21 January 2018

Re: New guidelines to evaluate the response to treatment in solid tumors (ovarian cancer).

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-185

21 January 2018

Comparative studies of tissue inhibitor of metalloproteinases-1 in plasma, serum and tumour tissue extracts from patients with primary colorectal cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-185

21 January 2018

TIMP1 and adverse prognosis in non-small cell lung cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882920

29 October 2018

Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-185

21 January 2018

Expression levels of vascular endothelial growth factor, matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 in the plasma of patients with ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-185

21 January 2018

Tissue inhibitor of metalloproteinase-1 inhibits apoptosis of human breast epithelial cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/20459644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary

1 reference

https://pubmed.ncbi.nlm.nih.gov/20459644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic impact of tissue inhibitor of matrix metalloproteinase-1 in esophageal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20459644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20459644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Growth stimulation of human keratinocytes by tissue inhibitor of metalloproteinases

1 reference

https://pubmed.ncbi.nlm.nih.gov/20459644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Positive correlation between inhibitors of matrix metalloproteinase 1 and matrix metalloproteinases in malignant ovarian tumor tissues

1 reference

https://pubmed.ncbi.nlm.nih.gov/20459644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High levels of tissue inhibitor of metalloproteinase-1 predict poor outcome in patients with breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20459644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gelatinases and their tissue inhibitors in ovarian tumors; TIMP-1 is a predictive as well as a prognostic factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/20459644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary tumor levels of tissue inhibitor of metalloproteinases-1 are predictive of resistance to chemotherapy in patients with metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20459644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Matrix metalloproteinase-2 (MMP-2) and -9 (MMP-9) and their tissue inhibitors (TIMP-1 and TIMP-2) in differential diagnosis between low malignant potential (LMP) and malignant ovarian tumours

1 reference

https://pubmed.ncbi.nlm.nih.gov/20459644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparative study of tissue inhibitor of metalloproteinases-1 levels in plasma and tumour tissue from patients with primary breast cancer and in plasma from patients with metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20459644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serous and mucinous ovarian tumors express different profiles of MMP-2, -7, -9, MT1-MMP, and TIMP-1 and -2

1 reference

https://pubmed.ncbi.nlm.nih.gov/20459644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of tissue inhibitors of metalloproteinases (TIMPs) in gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20459644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2407-10-185

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33902738&oldid=2195961536"